8.16
Daxor Corporation (DXR) 最新ニュース
Daxor Corporation (NASDAQ:DXR) Q4 2024 Earnings Call Transcript - MSN
Daxor Corporation Reports Strong 2024 Financial Growth - TipRanks
Daxor CFO Michel Robert J purchases $8,000 in company stock By Investing.com - Investing.com South Africa
Daxor CEO Michael Feldschuh purchases $25,804 in company stock - Investing.com
Daxor CFO Michel Robert J purchases $8,000 in company stock - Investing.com
Daxor Corporation Reports Robust Growth in Earnings Call - TipRanks
Earnings call transcript: Daxor Q4 2024 sees 116.5% revenue growth - Investing.com India
Earnings call transcript: Daxor Q4 2024 sees 116.5% revenue growth By Investing.com - Investing.com UK
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - GlobeNewswire
Daxor Corporation Reports Increase in NAV to $7.25 Per - GlobeNewswire
How Daxor Achieved Triple-Digit Revenue Growth: 60% Kit Sales Spike and DoD Contract Success - StockTitan
Daxor Corporation to Host Investor Conference Call to - GlobeNewswire
When Will Daxor Share Its 2024 Results? Key Date for Blood Volume Tech Investors - StockTitan
(DXR) Investment Report - Stock Traders Daily
Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - Marketscreener.com
How Daxor Achieved 116% Revenue Growth and Cash-Flow Break-Even: CEO Reveals Strategy - StockTitan
Daxor reports significant growth and strategic advances - Investing.com
Daxor reports significant growth and strategic advances By Investing.com - Investing.com South Africa
Daxor Corporation Reports Significant Growth and Strategic Developments in Blood Volume Measurement Technology - Nasdaq
How Daxor Doubled Revenue and Reached Cash-Flow Break-Even: CEO's Strategic Vision Revealed - StockTitan
How Daxor's 116.5% Revenue Explosion Could Transform Its Medical Diagnostics Business - StockTitan
Daxor Expands Blood Volume Analysis Services At Major Midwest Healthcare Center - Marketscreener.com
Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center - The Manila Times
How Daxor's No-Capital-Cost Diagnostic Service Is Quietly Expanding Across Major Healthcare Systems - StockTitan
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals - GlobeNewswire
Can Daxor's Hospital Expansion Strategy Transform Critical Care Outcomes? - StockTitan
Head to Head Comparison: Daxor (NASDAQ:DXR) versus iRhythm Technologies (NASDAQ:IRTC) - Defense World
Long Term Trading Analysis for (DXR) - Stock Traders Daily
Daxor Corporation Announces New Data on Blood Volume - GlobeNewswire
Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025 - The Manila Times
Duke and Yale Studies Validate Daxor's Blood Volume Analysis Superior Accuracy | DXR Stock News - StockTitan
Daxor to Exhibit at World's Largest Critical Care Conference - GlobeNewswire
Revolutionary ICU Blood Analysis Slashes Death Rates: Daxor's Game-Changing Data Revealed - StockTitan
DXRDaxor Corporation Latest Stock News & Market Updates - StockTitan
Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure - GlobeNewswire
Hidden Heart Failure Risk Affects Millions: Daxor's Revolutionary Blood Test Unlocks Life-Saving Treatment Path - StockTitan
Daxor Corporation Announces Multicenter Study Highlights Utility of Daxor's Blood Volume Analysis in Heart Failure Care - Marketscreener.com
Daxor Hikeson Blood Study - Baystreet.ca
New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care - GlobeNewswire
Major Clinical Study: Revolutionary Heart Failure Diagnostic Achieves Near-Perfect Accuracy - StockTitan
Daxor stock hits 52-week low at $6.83 amid market challenges - MSN
(DXR) Investment Analysis and Advice - Stock Traders Daily
Where are the Opportunities in (DXR) - Stock Traders Daily
Reviewing Becton, Dickinson and Company (NYSE:BDX) and Daxor (NASDAQ:DXR) - Defense World
(DXR) Technical Pivots with Risk Controls - Stock Traders Daily
Head to Head Contrast: Daxor (NASDAQ:DXR) versus Titan Medical (NASDAQ:TMDIF) - Defense World
大文字化:
|
ボリューム (24 時間):